Design and synthesis of fluoroquinophenoxazines that interact with human telomeric g-quadruplexes and their biological effects

Molecular Cancer Therapeutics

Volumn 1, Issue 2, 2001, Pages 103-120

  Duan, Wenhu ^a,e   Rangan, Anupama ^a   Vankayalapati, Hariprasad ^e   Kim, Mu Yong ^a,e   Zeng, Qingping ^a,f   Sun, Daekyu ^b   Han, Haiyong ^d   Fedoroff, Oleg Yu ^a,g   Nishioka, David ^c   Rha, Sun Young ^b,h   Izbicka, Elzbieta ^b   Von Hoff, Daniel D ^b,d   Hurley, Laurence H ^a,d,e,i  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b CTRC Institute for Drug Development   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f MONSANTO COMPANY   (United States)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h Yonsei University College of Medicine   (South Korea)

ⁱ University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); ENZYME INHIBITOR; QUINOLONE DERIVATIVE; TELOMERASE;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; CHROMOSOME; CONFORMATION; CYTOLOGY; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; HUMAN; LIGHT; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRENATAL DEVELOPMENT; SEA URCHIN; SYNTHESIS; TELOMERE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CHROMOSOMES; DNA TOPOISOMERASES, TYPE II; DNA, NEOPLASM; DRUG DESIGN; ENZYME INHIBITORS; FLUOROQUINOLONES; HUMANS; LIGHT; MAGNETIC RESONANCE SPECTROSCOPY; NUCLEIC ACID CONFORMATION; SEA URCHINS; SUBSTRATE SPECIFICITY; TELOMERASE; TELOMERE; TUMOR CELLS, CULTURED;

EID: 0035553175     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Wang, J. C. DNA topoisomerases. Annu. Rev. Biochem., 65: 635-692, 1996. (Pubitemid 26250622)
2. Reece, R. J., and Maxwell, A. DNA gyrase: structure and function. CRC Crit. Rev. Biochem. Mol. Biol., 26: 335-375, 1991. (Pubitemid 21892761)
3. Nitiss, J. L. Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim. Biophys. Acta, 1400: 63-81, 1998. (Pubitemid 28475096)
4. Yamakuchi, M., Nakata, M., Kawahara, K., Kitajima, I., and Maruyama, I. New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines. Cancer Lett., 119: 213-219, 1997. (Pubitemid 27478106)
5. Zeng, Q., Kwok, Y., Kerwin, S. M., Mangold, G., and Hurley, L. H. Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model. J. Med. Chem., 41: 4273-4278, 1998. (Pubitemid 28498750)
6. Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, J. O., Jenkins, T. C., Neidle, S., and Hurley, L. H. Inhibition of human telomerase by a G-quadruplex-interactive compound. J. Med. Chem., 40: 2113-2116, 1997. (Pubitemid 27284346)
7. Perry, P. J., Read, M. A., Davies, R. T., Gowan, S. M., Reszka, A. P., Wood, A. A., Kelland, L. R., and Neidle, S. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. J. Med. Chem., 42: 2679-2684, 1999. (Pubitemid 29344308)
8. Harrison, R. J., Gowan, S. M., Kelland, L. R., and Neidle, S. Human telomerase inhibition by substituted acridine derivatives. Bioorg. Med. Chem. Lett., 9: 2463-2468, 1999. (Pubitemid 29435519)
9. Read, M. A., Wood, A. A., Harrison, R. J., Gowan, S. M., Kelland, L. R., Dosanjh, H. S., and Neidle, S. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. J. Med. Chem., 42: 4538-4546, 1999. (Pubitemid 29530008)
10. Read, M., Harrison, R. J., Romagnoli, B., Tanious, F. A., Gowan, S. H., Reszka, A. P., Wilson, W. D., Kelland, L. R., and Neidle, S. Structure-based design of selective and potent G-quadruplex-mediated telomerase inhibitors. Proc. Natl. Acad. Sci. USA, 98: 4844-4849, 2001. (Pubitemid 32397044)
11. Wheelhouse, R. T., Sun, D., Han, H., Han, F. X., and Hurley, L. H. Cationic porphyrins as telomerase inhibitors: the interaction of tetra(N-methyl-4-pyridyl)porphine with quadruplex DNA. J. Am. Chem. Soc. 120: 3261-3262, 1998. (Pubitemid 28204540)
12. Han, F. X., Wheelhouse, R. T., and Hurley, L. H. Interactions of TMPyP4 and TMPyP2 with quadruplex DNA. Structural basis for the differential effects on telomerase inhibition. J. Am. Chem. Soc., 121: 3561-3570, 1999. (Pubitemid 29200264)
13. Han, H., Rangan, A., Langley, D. R., and Hurley, L. H. Selective interaction of cationic porphyrins with G-quadruplex structures. J. Am. Chem. Soc. 123: 8902-8913, 2001. (Pubitemid 32884711)
14. Riou, J-F., Mailliet, P., Laoui, A., Renou, E., Petigenet, O., Guittat, L., and Mergny, J-L. Apoptosis, cell senescence, and telomere shortening induced by a new series of specific G-quadruplex DNA ligand. Proc. Am. Assoc. Cancer Res. 42: 837, 2001.
15. Koeppel, F., Riou, J-F., Laoui, A., Malliet, P., Arimondo, P. B., Labit, D., Petigenet, O., Hélène, C., and Mergny, J-L. Ethidium derivatives bind to G-quartets, inhibit telomerase, and act as fluorescent probes for quadruplexes. Nucleic Acids Res., 29: 1087-1096, 2001. (Pubitemid 32186194)
16. Gowan, S. M., Brunton, L., Valenti, M., Heald, R., Read, M. A., Harrison, J. R., Stevens, M. F. G., Neidle, S., and Kelland, L. R. Preclinical antitumor properties of G-quadruplex-interactive small molecule inhibitors of telomerase. Proc. Am. Assoc. Cancer Res., 42: 86, 2001.
17. Gellert, M., Lipsett, M. N., and Davies, D. R. Helix formation by guanylic acid. Proc. Natl. Acad. Sci. USA, 48: 2013-2018, 1962.
18. Henderson, E., Hardin, C. C., Walk, S. K., Tinoco, K., Jr., and Blackburn, E. H. Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine-guanine base pairs. Cell, 51: 899-908, 1987.
19. Sundquist, W. I., and Klug, A. Telomeric DNA dimerizes by formation of guanine tetrads between hairpin loops. Nature (Lond.), 342: 825-829, 1989. (Pubitemid 20023821)
20. Sundquist, W. I., and Heaphy, S. Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA. Proc. Natl. Acad. Sci. USA, 90: 3393-3397, 1993. (Pubitemid 23111372)
21. Sen, D., and Gilbert, W. Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis. Nature (Lond.), 334: 364-366, 1988.
22. Hammond-Kosack, M. C., Kilpatrick, M. W., and Docherty, K. Analysis of DNA structure in the human insulin gene-linked polymorphic region in vivo. J. Mol. Endocrinol., 9: 221-225, 1992.
23. Murchie, A. I., and Lilley, D. M. Retinoblastoma susceptibility genes contain 5′ sequences with a high propensity to form guanine-tetrad structures. Nucleic Acids Res., 20: 49-53, 1992.
24. Hurley, L. H. DNA and associated targets for drug design. J. Med. Chem., 32: 2027-2033, 1989. (Pubitemid 19224161)
25. Giraldo, R., and Rhodes, D. The yeast telomere-binding protein RAP1 binds to and promotes the formation of DNA quadruplexes in telomeric DNA. EMBO J., 13: 2411-2420, 1994. (Pubitemid 24157616)
26. Fang, G., and Cech, T. R. The β-subunit of Oxytricha telomere-binding protein promotes G-quartet formation by telomeric DNA. Cell, 74: 875-885, 1993. (Pubitemid 23270607)
27. Arimondo, P. B., Riou, J. F., Mergny, J. L., Tazi, J., Sun, J. S., Garestier, T., and Hélène, C. Interaction of human DNA topoisomerase I with G-quartet structures. Nucleic Acids Res., 28: 4832-4838, 2000. (Pubitemid 32014252)
28. Hanakahi, L. A., Sun, H., and Maizels, N. High affinity interactions of nucleolin with G-G-paired rDNA. J. Biol. Chem., 274: 15908-15912, 1999.
29. Oliver, A. W., Bogdarina, I., and Kneale, G. G. Preferential binding of Fd gene 5 protein to tetraplex nucleic acid structures. J. Mol. Biol., 301: 575-584, 2000.
30. Harrington, C., Lan, Y., and Akman, S. A. The identification and characterization of G4-DNA resolvase activity. J. Biol. Chem., 272: 24631-24636, 1997. (Pubitemid 27418680)
31. Gilson, E., Roberge, M., Giraldo, R., Rhodes, D., and Glasser, S. M. Distortion of the DNA double helix by RAP1 at silencers and multiple telomeric binding-sites. J. Mol. Biol., 231: 293-310, 1993. (Pubitemid 23188254)
32. Suzuki, N., Shimamoto, A., Imamura, O., Kuromitsu, J., Kitao, S., Goto, M., and Furuichi, Y. DNA helicase activity in Werner's syndrome gene product synthesized in a baculovirus system. Nucleic Acids Res., 25: 2973-2978, 1997. (Pubitemid 27331388)
33. Sun, H., Karow, J. K., Hickson, I. D., and Maizels, N. The Bloom's syndrome helicase unwinds G4 DNA. J. Biol. Chem., 273: 27587-27592, 1998. (Pubitemid 28500481)
34. Sun, H., Bennett, R. J., and Maizels, N. The Saccharomyces cerevisiae Sgs1 helicase efficiently unwinds G-G paired DNAs. Nucleic Acids Res., 27: 1978-1984, 1999. (Pubitemid 29209557)
35. Schaffitzel, C., Berger, I., Postberg, J., Hanes, J., Lipps, H. J., and Plückthu, A. In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei. Proc. Natl. Acad. Sci. USA, 98: 8572-8577, 2001. (Pubitemid 32678069)
36. Izbicka, E., Wheelhouse, R. T., Raymond, E., Davidson, K. K., Lawrence, R. A., Sun, D., Windle, B. E., Hurley, L. H., and Von Hoff, D. D. Effects of cationic porphyrins as G-quadruplex-interactive agents in human tumor cells. Cancer Res., 59: 639-644, 1999. (Pubitemid 29076062)
37. Mergny, J-L., and Hélène, C. G-quadruplex DNA: a target for drug design. Nat. Med., 4: 1366-1367, 1998. (Pubitemid 28553455)
38. Han, H., and Hurley, L. H. G-quadruplex DNA: a potential target in anticancer drug design. Trends Pharmacol. Sci., 21: 136-142, 2000. (Pubitemid 30190138)
39. Hurley, L. H., Wheelhouse, R. T., Sun, D., Kerwin, S. M., Salazar, M., Fedoroff, O. Yu., Han, F. X., Han, H., Izbicka, E., and Von Hoff, D. D. G-quadruplexes as targets for drug design. Pharmacol. Ther., 85: 141-158, 2000. (Pubitemid 30160784)
40. Kerwin, S. M. G-quadruplex DNA as a target for drug design. Curr. Pharm. Des., 6: 441-471, 2000. (Pubitemid 30396406)
41. Jenkins, T. C. Targeting multi-stranded DNA structures. Curr. Med. Chem., 7: 99-115, 2000. (Pubitemid 30395451)
42. Sun, D., and Hurley, L. H. Targeting telomeres and telomerase. In: J. B. Chaires, and M. J. Waring (eds.), Methods in Enzymology, Vol. 340, pp. 573-592. San Diego: Academic Press, 2001.
43. Raymond, E., Sun, D., Chen, S-F., Windle, B., and Von Hoff, D. D. Agents that target telomerase and telomeres. Curr. Opin. Biotechnol., 7: 583-591, 1996. (Pubitemid 26400060)
44. Kelland, L. R. Telomerase: biology and phase 1 trials. Lancet, 2: 95-102, 2001.
45. Bearss, D. J., Hurley, L. H., and Von Hoff, D. D. Telomere maintenance mechanisms as a target for drug development. Oncogene, 19: 6632-6641, 2000. (Pubitemid 32197702)
46. 2+self-assembly complex in the presence of topoisomerase II. Biol. Chem., 274: 17226-17235, 1999.
47. Sun, D., Hurley, L. H., and Von Hoff, D. D. Telomerase assay using biotinylated-primer extension and magnetic separation of the products. BioTechniques, 25: 1046-1051, 1998. (Pubitemid 29005819)
48. Han, H., Hurley, L. H., and Salazar, M. A DNA polymerase stop assay for G-quadruplex-interactive compounds. Nucleic Acids Res., 27: 537-542, 1999. (Pubitemid 29210020)
49. Fedoroff, O. Yu., Salazar, M., Han, H., Chemeris, V. V., Kerwin, S. M., and Hurley, L. H. NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry, 37: 12367-12374, 1998. (Pubitemid 28427520)
50. Wang, Y., and Patel, D. J. Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. Structure (Lond.), 1: 263-282, 1993. (Pubitemid 2031126)
51. INSIGHT II Molecular Modeling, Molecular Simulations Inc., San Diego, 2000.
52. Luty, B. A., Wasserman, Z. R., Stouten, P. F. W., Hodge, C. N., Zacharias, M., and McCammon, J. A. A molecular mechanics/grid method for the evaluation of ligand-receptor interactions. J. Comput. Chem., 16: 454-464, 1995.
53. Mossman, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
54. Izbicka, E., Nishioka, D., Marcell, V., Raymond, E., Davidson, K. K., Lawrence, R. A., Wheelhouse, R. T., Hurley, L. H., Wu, R. S., and Von Hoff, D. D. Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos. Anti-Cancer Drug Des., 14: 355-365, 1999.
55. Nishioka, D., Marcell, V., Cunningham, M., Khan, M., Von Hoff, D., and Izbicka, E. The use of early sea urchin embryos in anticancer drug testing. Methods in Molecular Medicine, Humana Press, in press, 2001.
56. Chu, D. T. W., and Maleczka, R. E., Jr. Synthesis of 4-oxo-4H-quino-[2: 3,4-i, j][1,4]benoxazine-5-carboxylic acid derivatives. J. Heterocycl. Chem., 24: 453-456, 1987. (Pubitemid 17107866)
57. Sahai, B. M., and Kaplan, J. G. A quantitative decatenation assay for type II topoisomerases. Anal. Biochem., 156: 364-379, 1986. (Pubitemid 16051773)
58. Marini, J. C., Miller, K. G., and Englund, P. T. Decatenation of kinetoplast DNA by topoisomerases. J. Biol. Chem., 225: 4976-4979, 1980.
59. Zahler, A. M., Williamson, J. R., Cech, R. R., and Prescott, D. M. Inhibition of telomerase by G-quartet DNA structures. Nature (Lond.), 350: 718-720, 1991. (Pubitemid 21912306)
60. Weitzmann, M. N., Woodford, K. J., and Usdin, K. The development and use of a DNA polymerase arrest assay for the evaluation of parameters affecting intrastrand tetraplex formation J. Biol. Chem., 271: 20958-20964, 1996. (Pubitemid 26281887)
61. Izbicka, E., Nishioka, D., Wu, R., Von Hoff, D., Weitman, S., and Hurley, L. H. Antiproliferative and chromosome destabilizing effects of novel quinolones. Proc. Am. Assoc. Cancer Res., 40: 16, 1999.
62. Nishioka, D., Wu, R., Rha, S., Von Hoff, D., and Izbicka, E. HMAF (6-hydroxymethylacylfulvene, MGI 114) induces chromosome destabilization in developing sea urchin embryos. Proc. Am. Assoc. Cancer Res., 40: 3, 1999.
63. Nishioka, D., Wu, R., Von Hoff, D., and Izbicka, E. Chromosome effects of ecteinascidin ET-743 (ET-743) in a sea urchin embryo model. Proc. Am. Assoc. Cancer Res., 40: 300, 1999.
64. Permana, P. A., Snapka, R. M., Shen, L. L., Chu, D. T. W., Clement, J. J., and Plattner, J. J. Quinobenzoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitors. Biochemistry, 33: 11333-11339, 1994. (Pubitemid 24304299)
65. 2+complex on DNA: a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex. J. Med. Chem., 38: 408-424, 1995.
66. Kirk, K., Harmon, B., Reichardt, I., Sedat, J., and Blackburn, E. Block in anaphase chromosome separation caused by telomerase template mutation. Science (Wash. DC), 275: 1478-1481, 1997. (Pubitemid 27111296)
67. van Steensel, B., Smogorzewska, A., and de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell, 92: 401-413, 1998. (Pubitemid 28093017)